Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?

NCT01048268 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: glucose-dependent insulinotropic polypeptide
DRUG: Placebo

Sponsor

University Hospital, Gentofte, Copenhagen